Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-10
DOI
10.1038/s41598-019-55239-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Off the shelf T cell therapies for hematologic malignancies
- (2018) Bruce J. McCreedy et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR
- (2018) Miguel-Angel Perales et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia
- (2018) M. Vela et al. CANCER LETTERS
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
- (2018) May Daher et al. CURRENT OPINION IN IMMUNOLOGY
- Manufacturing development and clinical production of NKG2D chimeric antigen receptor–expressing T cells for autologous adoptive cell therapy
- (2018) Joana M. Murad et al. CYTOTHERAPY
- Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
- (2018) David Porter et al. Journal of Hematology & Oncology
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia
- (2018) Elad Jacoby et al. AMERICAN JOURNAL OF HEMATOLOGY
- The promise of CAR T-cell therapy in aggressive B-cell lymphoma
- (2018) Ranjit Nair et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
- (2018) Hasan Mollanoori et al. HUMAN IMMUNOLOGY
- The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
- (2018) Matthew H Forsberg et al. Therapeutics and Clinical Risk Management
- Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
- (2018) Sebastian Giebel et al. BONE MARROW TRANSPLANTATION
- Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
- (2018) Yixin Zou et al. Journal of Hematology & Oncology
- Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
- (2018) Maria Castella et al. Molecular Therapy-Methods & Clinical Development
- IL-2 mediates NK cell proliferation but not hyperactivity
- (2017) Richa Sharma et al. IMMUNOLOGIC RESEARCH
- NK-92 cell, another ideal carrier for chimeric antigen receptor
- (2017) Wan-ning Wang et al. Immunotherapy
- Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review
- (2017) Faiz Anwer et al. Immunotherapy
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
- (2017) Kevin G. Pinz et al. Oncotarget
- Cellular Immunotherapy in B-Cell Malignancy
- (2017) Mark-Alexander Schwarzbich et al. Oncology Research and Treatment
- OP9 Feeder Cells Are Superior to M2-10B4 Cells for the Generation of Mature and Functional Natural Killer Cells from Umbilical Cord Hematopoietic Progenitors
- (2017) Lara Herrera et al. Frontiers in Immunology
- Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells
- (2016) Mark B. Geyer et al. CYTOTHERAPY
- CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies
- (2016) Annette Romanski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparison of Human Neonatal and Adult Blood Leukocyte Subset Composition Phenotypes
- (2016) Savit B. Prabhu et al. PLoS One
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
- (2015) Markus Granzin et al. CYTOTHERAPY
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
- (2015) David L. Hermanson et al. Frontiers in Immunology
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are natural killer cells superior CAR drivers?
- (2014) Hans Klingemann OncoImmunology
- Novel targeted therapies in acute lymphoblastic leukemia
- (2013) Craig A. Portell et al. LEUKEMIA & LYMPHOMA
- GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
- (2013) Okjae Lim et al. PLoS One
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34+progenitor cells
- (2011) Maria João Pinho et al. CELL COMMUNICATION AND ADHESION
- Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens
- (2011) Laurent Boissel et al. LEUKEMIA & LYMPHOMA
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytotoxic Function of Umbilical Cord Blood Natural Killer Cells: Relevance to Adoptive Immunotherapy
- (2011) Syh-Jae Lin et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells
- (2009) Michael R. Verneris et al. BRITISH JOURNAL OF HAEMATOLOGY
- Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection
- (2009) Hitoshi Kuroda et al. JOURNAL OF VIROLOGICAL METHODS
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Phenotypic and Functional Heterogeneity of Natural Killer Cells from Umbilical Cord Blood Mononuclear Cells
- (2008) Yan-Ying Fan et al. IMMUNOLOGICAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started